Søgning
Søgning på udtrykket 'covid' giver 53 resultater
Dokumenter [9]
Sider [3]
Nyt fra tidsskrifterne [+20]
Aktuelle smitsomme sygdomme [+20]
Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.
Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem.
Ændringer siden version 29:
Indikationer for COVID-19 test er tilføjet.
COVID-19 pandemien: Erfaringer vedrørende migranter og etniske
minoriteters sundhed
Invitation til møde den 20. maj 2022
DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er).
Dette holdningspapir omhandler baggrunden for anbefalingen.
Virtuelt årsmøde med fokus på COVID-19 den 7. maj 2021
Afholdt fredag den 25. september 2020 som onlinemøde med fokus på COVID-19
Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale
Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.
Borrelia:
Anne-Mette Lebech (tovholder), Christian Brandt, Fredrikke Christie Knudtzen, Helene Mens, Jacob Bodilsen, Sigurdur Skarphédinsson
Borrelia klaringsrapport (2014),
Diagnostik og behandling af Lyme neuroborreliose (2021),
COVID-19:
Behandling af COVID-19:
Michael Dalager-Pedersen (tovholder), Marie Helleberg, Gitte Kronborg, Isik Somuncu, Merete Storgaard, Lothar Wiese
COVID-19 retningslinje (2024v28),
Post-COVID-19:
Jacob Bodilsen, Christian Brandt, Stine Jo.
diagnostiske undersøgelser ikke forsinke empirisk behandling ved symptomer herpå.
Vaccinationer:
Primær vaccination foretages mod Streptococcus pneumoniae, Haemophilus influenzae type B og Neisseria meningitidis. Årlig influenza-vaccination (samt COVID-19 vaccination ud fra aktuelle rekommandationer) anbefales på grund af øget risiko for sekundær bakteriel infektion.
Pneumokokker.
Den 20-valent konjugerede pneumokok vaccine, PCV20 (Apexxnar), anbefales til voksne.
Professor Henrik Nielsen kommenterer: Så kom den endelig. Længe ventet, med spænding imødeset. Fagfællebedømt artikel om BioNTech/Pfizers BNT162b2 mRNA vaccine mod COVID-19. Selvfølgelig i NEJM og naturligvis af stor aktuel interesse, men vil også blive stående som en klassiker i medicinsk litteratur. En milepæl i vaccinologiens historie, blandt andet fordi der er anvendt en ny teknologisk platform og fordi studiet er kommet i mål på rekordtid.
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
PLoS One Infectious Diseases
22.04.2025
ear period prior to COVID-19. Data were analyzed from 109,167 ILI notifications collected between March 2015 and March 2019 through “The Iran Influenza Surveillance System (IISS)”. Spatial scan statistics was utilized to identify significant spatial, temporal, and spatiotemporal clusters of ILI cases. The average age of patients was 40 years (range: 1–117), with females comprising 53% of cases. Males exhibited a higher significant case fatality rate (CFR= 3.28%) compared to females (CFR=2.46%)(P-value
Journal of Medical Virology
20.04.2025
Journal of Medical Virology, Volume 97, Issue 4, April 2025.
BMJ Open
20.04.2025
. Objective. The UK government’s response to the COVID-19 pandemic included a ‘test, trace and isolate’ strategy. Testing services for healthcare workers, care homes and schools accounted for the greatest spend and volume of tests. We reviewed relevant literature to identify common and unique barriers and facilitators to engaging with each of these testing services. . Design. Scoping review. . Search strategy.
International Journal of Infectious Diseases
19.04.2025
Post-acute sequelae of COVID-19 (PASC), also generally known as ‘Long COVID’, refers to the condition where individuals experience persistent symptoms and complications, following an acute SARS-COV-2 infection. This condition has emerged as a significant public health challenge, with a recently estimated worldwide PASC prevalence of 6.6-10.3%, aligning with the World Health Organization’s (WHO) estimates of 10-20% [1,2].
BMC Infectious Diseases
19.04.2025
. Background. The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has profoundly impacted global health, leading to over 74 million confirmed cases and 1.67 million deaths by December 2020. In Saudi Arabia, extensive measures were implemented to mitigate the spread of the virus. Kidney transplant recipients, due to their immunosuppressed status, are particularly vulnerable to severe COVID-19 outcomes.
Journal of Infectious Diseases
18.04.2025
Abstract . Assessing the time-varying effectiveness of COVID-19 vaccines is critical to guiding vaccine strategies and public health policies. We developed a Bayesian framework to estimate the waning vaccine effectiveness of various doses of CoronaVac and Comirnaty based on population-level surveillance data. We applied this framework to data on a large Omicron BA.2 epidemic in Hong Kong from January to May 2022.
BMC Infectious Diseases
18.04.2025
. Background. The COVID-19 pandemic represented a healthcare challenge of unparalleled magnitude worldwide. As patients recovered from the acute infection, a new challenge emerged, i.e., the development of post-acute symptoms. The main goal of this study was to evaluate the trajectory of cognitive symptoms since the acute phase of COVID-19 among patients followed through a telehealth program in Brazil. . Methods.
BMC Infectious Diseases
18.04.2025
. Background. The disability-adjusted life year (DALY) approach gives policymakers a clear understanding of the scale of the health issue. This study aimed to estimate DALYs attributed to coronavirus disease 2019 (COVID-19) for the population of Bushehr province and, by extension, the Iranian population during the first three years of the pandemic. . Method.
JAMA Network Open New Online
18.04.2025
Neurology
JAMA Network Open New Online
18.04.2025
This cohort study examines whether COVID-19 pandemic–related exposures are associated with changes in cognitive function among women aged 51 to 76 years.
PLoS One Infectious Diseases
18.04.2025
by Colby Parkinson, Xiangyou Shen, Megan MacDonald, Samuel W. Logan, Lydia Gorrell, Kreg Lindberg . Outdoor recreation provided a crucial way to maintain physical activity, reduce stress, and preserve a sense of normalcy during the COVID-19 pandemic. This study assessed the relationship between outdoor recreation and mental health in the context of COVID-19. Cross-sectional online survey data were collected in early 2021 from a sample (n = 503) representative of the U.S.
PLoS One Infectious Diseases
18.04.2025
hrin Schlößler, Nino Chikhradze, Romy Lauer, Michael Pentzek, Achim Mortsiefer, Horst Christian Vollmar, Ina Carola Otte . Background This article explores the psychological burden experienced by medical assistants (MAs) in General Practices during the Covid-19 pandemic (Corona virus disease 2019 (SARS-CoV-2)) in Germany.
Clinical Microbiology and Infection
17.04.2025
Post-COVID condition (PCC) remains poorly understood, especially in clinically vulnerable groups. Within the ORCHESTRA Project, we applied the Delphi approach to drive recommendations for the diagnosis, management, and prevention of PCC in people living with HIV (PWH) and patients affected by rheumatological diseases (RD) and haematological malignancies (HM).
BMC Infectious Diseases
17.04.2025
. Background. This study investigated the clinical and molecular characteristics of Staphylococcus aureus (S. aureus) isolates from patients with coronavirus disease 19 (COVID- 19) at West China Hospital between December 1, 2022 and January 31, 2023. . Methods.
BMC Infectious Diseases
16.04.2025
. Background. Several studies explored factors related to adverse clinical outcomes among COVID-19 patients but lacked analysis of the impact of the temporal data shifts on the strength of association between different predictors and adverse outcomes.
BMC Infectious Diseases
16.04.2025
Background. The global increase in maternal and congenital syphilis cases over the past decade has been substantial. In south Brazil, preexisting maternal and congenital syphilis epidemics have been worsened since the onset of COVID- 19. We evaluated the impact of the COVID- 19 pandemic on the epidemiological trends of maternal and congenital syphilis in Porto Alegre, Brazil. . Methods.
JAMA Network Open New Online
16.04.2025
This quality improvement study evaluates whether personal protective equipment (PPE) deescalation guidelines in Singapore was associated with staff COVID-19 incidence as well as the environmental sustainability outcomes of PPE deescalation.
Infection
16.04.2025
. Background. The objective of this clinical trial is to evaluate the efficacy and safety of IL-6 driven personalized treatment strategy with tocilizumab in patients with severe COVID-19 pneumonia. . Trial design. Randomized, controlled, open-label, single-center trial of a tocilizumab treatment strategy in adult patients hospitalized with severe COVID-19 pneumonia and IL-6 serum levels > 40 pg/mL. . Methods.
Journal of Medical Virology
16.04.2025
Journal of Medical Virology, Volume 97, Issue 4, April 2025.
BMJ Open
15.04.2025
. Objectives. This cross-sectional study aimed to assess parents’ knowledge, attitude and practice (KAP) towards myopia amidst increased children’s online course participation during the COVID-19 pandemic, potentially impacting visual health. . Design. The study adopted a cross-sectional design to analyse parent KAP regarding myopia. . Setting and participants.
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
21.04.2025
Better diagnostics, more focused treatment, and deeper understanding of individualized symptoms could all take major steps forward this year. . Medscape Medical News
Medscape Infectious Diseases
14.04.2025
In patients hospitalised for COVID-19, fatigue, memory and cognitive problems worsened between years 2 and 3 post-discharge; nearly one third of patients developed PEM at 3 years, a study finds. . Medscape News UK
ProMED
13.04.2025
ttp://
www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases.
www.isid.org . Date: Thu 10 Apr 2025 . Source: CIDRAP (Center for Infectious Disease Research & Policy). [edited] .
www.cidrap.umn.edu/covid-19/using-study-design-past-researchers-again-show-
covid-19-airborne . . . In 1959, researchers built a facility near Pretoria, South Africa, to. study the airborne route of tuberculosis transmission, replicating an.
Medscape Infectious Diseases
8.04.2025
NIH cuts target $1.6 billion RECOVER initiative to study and improve treatment of long COVID, putting further research gains in doubt. . Medscape Medical News
Medscape Infectious Diseases
8.04.2025
New research links multisystem inflammatory syndrome in children with COVID-19 to Epstein-Barr virus reactivation, revealing immune dysfunction and potential treatment targets. . Medscape Medical News
Medscape Infectious Diseases
4.04.2025
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's COVID-19 vaccine, the company told Reuters on. . Reuters Health Information
ProMED
2.04.2025
******************************************************. A ProMED-mail post.
www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases.
www.isid.org . In this update: . [1] Russia: Publication of daily
COVID-19 reports halted . [2] Macau:
COVID-19 positive rate at 40%; 2 health bureaus urge. vaccination . [3] Hong Kong: Local influenza activity continues to decline,
COVID-19. activity begins to rise slightly .
Morbidity and Mortality Weekly Report (MMWR)
1.04.2025
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021.
Morbidity and Mortality Weekly Report (MMWR)
27.03.2025
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021.
ECDC COVID-19 updates
26.03.2025
COVID-19 vaccination reduced the risk of developing ‘long COVID’ by approximately 27% in adults fully vaccinated before infection, according to a literature review carried out by the European Centre for Disease Prevention and Control (ECDC).
ECDC COVID-19 updates
26.03.2025
This report addresses whether COVID-19 vaccination also reduces the risk and/or duration of a wide range of post-acute COVID-19 symptoms, commonly referred to as ‘long COVID’.
ECDC COVID-19 updates
22.03.2025
ECDC is supporting a large number of targeted External Quality Assessment (EQA) schemes with voluntary participation by reference or primary laboratories, which are active members of EU surveillance networks.
Medscape Infectious Diseases
19.03.2025
After COVID-19, RSV cases appear earlier and result in more severe illness in infants, with increased oxygen and ventilation needs, a new study reports. . Medscape News UK
Medscape Infectious Diseases
14.03.2025
Daily oral drug reduced COVID-19 risk by 67% in exposed but uninfected adults . Medscape Medical News
Medscape Infectious Diseases
14.03.2025
Measles cases in the European region doubled in 2024 to a more than 25-year-high, the World Health Organisation and UNICEF said on Thursday, as they urged action to restore. . Reuters Health Information
Eurosurveillance latest updates
14.03.2025
. Background. Evolution of SARS-CoV-2 is continuous. . . Aim. Between 01/2020 and 02/2022, we studied SARS-CoV-2 variant epidemiology, evolution and association with COVID-19 severity. . . Methods. In nasopharyngeal swabs of COVID-19 patients (n = 1,762) from France, Italy, Spain, and the Netherlands, SARS-CoV-2 was investigated by reverse transcription-quantitative PCR and whole-genome sequencing, and the virus variant/lineage (NextStrain/Pangolin) was determined.
Medscape Infectious Diseases
14.03.2025
Germany's foreign intelligence service in 2020 put at 80%-90% the likelihood that the coronavirus behind the COVID-19 pandemic was accidentally released from China's Wuhan. . Reuters Health Information
Medscape Infectious Diseases
13.03.2025
The study quantifies the direct and indirect harms to life caused by the pandemic. . Medscape Medical News
Medscape Infectious Diseases
13.03.2025
Vaccinated persons had fewer emergency medical visits than those who were not vaccinated. . Medscape Medical News
Medscape Infectious Diseases
12.03.2025
Adjusted odds ratio showed similar prevalence of long COVID in cancer survivors and controls. . Medscape Medical News